Barts Cancer Institute - Queen Mary University of London

Thursday Seminar Series
2018-03-22 12:30 - 13:30 UTC
For this week’s installment of the BCI’s Thursday Seminar Series, Prof. Mark Cragg – Professor of Experimental Cancer Research and Director of the i4PhD Cancer Immunology Pathway – shall be speaking. Prof. Cragg’s research group is interested in two main areas: antibodies and small molecule inhibitors with the aim of understanding how these therapeutics function to delete tumour cells and how they might be augmented.
This seminar shall be in the Lister and Young Seminar Room, from 12.30pm-1.30pm.
Title: TBC
For more information about Prof. Mark Cragg, please click HERE.
